Selective inhibition of activated stellate cells and protection from carbon tetrachloride-induced liver injury in rats by a new ppar? Agonist kr62776

Archives of Pharmacal Research

Volumn 33, Issue 3, 2010, Pages 433-442

  Bae, Myung Ae ^a   Rhee, Sang Dal ^a   Jung, Won Hoon ^a   Ahn, Jin Hee ^a   Song, Byoung Joon ^b   Cheon, Hyae Gyeong ^a  

^a Korea Research Institute of Chemical Technology   (South Korea)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

A smooth muscle actin; Collagen a1(I); KR62776; PPAR; Stellate cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARBON TETRACHLORIDE; CD36 ANTIGEN; CELL CYCLE PROTEIN; CYCLIN B; CYCLIN D1; CYCLIN DEPENDENT KINASE 2; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; KR 62776; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PROTEIN P21; PROTEIN P27; RNA; UNCLASSIFIED DRUG; ACTIN; INDAN DERIVATIVE; MESSENGER RNA; OXIME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTECTIVE AGENT; SMOOTH MUSCLE ACTIN, RAT;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL PROTECTION; CELL VIABILITY; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG STRUCTURE; FLOW CYTOMETRY; IMMUNOBLOTTING; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STELLATE CELL; ANIMAL; CELL CYCLE; CELL STRAIN HEPG2; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DOSE RESPONSE; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; MALE; METABOLISM; PATHOLOGY; TIME; TOXIC HEPATITIS; WISTAR RAT;

ACTINS; ANIMALS; APOPTOSIS; CARBON TETRACHLORIDE; CELL CYCLE; CELL CYCLE PROTEINS; CELL PROLIFERATION; CYTOPROTECTION; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG-INDUCED LIVER INJURY; GENE EXPRESSION REGULATION; HEP G2 CELLS; HEPATIC STELLATE CELLS; HUMANS; INDANS; LIVER; LIVER CIRRHOSIS; MALE; OXIMES; PPAR GAMMA; PROTECTIVE AGENTS; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS;

EID: 77953648412     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-010-0313-3     Document Type: Article

References (35)

1. Ahn, J. H., Shin, M. S., Jung, S. H., Kang, S. K., Kim, K. R., Rhee, S. D., Jung, W. H., Yang, S. D., Kim, S. J., Woo, J. R., Lee, J. H., Cheon, H. G., and Kim, S. S., Indene derivatives: A novel template for peroxosome proliferatoractivated receptor γ (PPARγ) agonists. J. Med. Chem., 49, 4781-4784 (2006).
2. Bae, M. A., Pie, J. E., and Song, B. J., Acetaminophen induces apoptosis of C6 glioma cells by activating the c-Jun NH2-terminal protein kinase-related cell death pathway. Mol. Pharmacol., 60, 847-856 (2001).
3. Bae, M. A. and Song, B. J., Critical role of c-Jun N-terminal protein kinase activation in troglitazone-induced apoptosis of human HepG2 hepatoma cells. Mol. Pharmacol., 63, 401-408 (2003).
4. Baroni, G. S., D'Ambrosio, L., Curto, P., Casini, A., Mancini, R., Jezequel, A. M., and Benedetti, A., Interferon gamma decreases hepatic stellate cell activation and extracellular matrix deposition in rat liver fibrosis. Hepatology, 23, 1189-1199 (1996).
5. Berger, J. and Moller, D. E., The mechanisms of action of PPARs. Annu. Rev. Med., 53, 409-435 (2002).
6. Blazejewski, S., Preaux, A. M., Mallat, A., Brocherion, I., Mavier, P., Dhumeaux, D., Hartmann, D., Schuppan, D., and Rosenbaum, J., Human myofibroblast-like cells obtained by outgrowth are representative of the fibrogenic cells in the liver. Hepatology, 22, 788-797 (1995).
7. Bruck, R., Genina, O., Aeed, H., Alexiev, R., Nagler, A., Avni, Y., and Pines, M., Halofuginone to prevent and treat thioacetamide- induced liver fibrosis in rats. Hepatology, 33, 379-386 (2001).
8. Date, M., Fukuchi, K., Morita, S., Takahashi, H., and Ohura, K., 15-Deoxy-delta12,14-prostaglandin J2, a ligand for peroxisome proliferators-activated receptor-gamma, induces apoptosis in human hepatoma cells. Liver Int., 23, 460-466 (2003).
9. Dubuquoy, L., Dharancy, S., Nutten, S., Petterson, S., Auwerx, J., and Desreumaux, P., Role of peroxisome proliferatoractivated receptor and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet, 360, 1410-1418 (2000).
10. Enomoto, N., Takei, Y., Hirose, M., Konno, A., Shibuya, T., Matsuyama, S., Suzuki, S., Kitamura, K. I., and Sato, N., Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptorgamma, pioglitazone. J. Pharmacol. Exp. Ther., 306, 846-854 (2003).
11. Friedman, S. L., Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem., 275, 2247-2250 (2000).
12. Galli, A., Crabb, D. W., Ceni, E., Salzano, R., Mello, T., Svegliati-Baroni, G., Ridolfi, F., Trozzi, L., Surrenti, C., and Casini, A., Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology,122, 1924-1940 (2002).
13. Garcia, L., Hernandez, I., Sandoval, A., Salazar, A., Garcia, J., Vera, J., Grijalva, G., Muriel, P., Margolin, S., and Armendariz-Borunda, J., Pirfenidone effectively reverses experimental liver fibrosis. J. Hepatol., 37, 797-805 (2002).
14. Geerts, A., Lazou, J. M., De Bleser, P., and Wisse, E., Tissue distribution, quantitation and proliferation kinetics of fatstoring cells in carbon tetrachloride-injured rat liver. Hepatology, 13, 1193-1202 (1991).
15. Kawaguchi, K., Sakaida, I., Tsuchiya, M., Omori, K., Takami, T., and Okita, K., Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. Biochem. Biophys. Res. Commun., 315, 187-195 (2004).
16. Kon, K., Ikejima, K., Hirose, M., Yoshikawa, M., Enomoto, N., Kitamura, T., Takei, Y., and Sato, N., Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem. Biophys. Res. Commun., 291, 55-61 (2002).
17. Li, L., Tao, J., Davaille, J., Feral, C., Mallat, A., Rieusset, J., Vidal, H., and Lotersztajn, S., 15-Deoxy-δ12,14-prostaglandin J2 induces apoptosis of human hepatic myofibroblasts. A pathway involving oxidative stress independently of peroxisome-proliferator-activated receptors. J. Biol. Chem., 276, 38152-38158 (2001).
18. Marra, F., Efsen, E., Romanelli, R. G., Caligiuri, A., Pastacaldi, S., Batignani, G., Bonacchi, A., Caporale, R., Laffi, G., Pinzani, M., and Gentilini, P., Ligands of peroxisome proliferator-activated receptor g modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology, 119, 466-478 (2000).
19. Milani, S., Herbst, H., Schuppan, D., Kim, K. Y., Riecken, E. O., and Stein, H., Procollagen expression by nonparenchymal rat liver cells in experimental biliary fibrosis. Gastroenterology, 98, 175-184 (1990).
20. Miyahara, T., Schrum, L., Rippe, R., Xiong, S., Yee, H. F. Jr, Motomura, K., Anania, F. A., Willson, T. M., and Tsukamoto, H., Peroxisome proliferator-activated receptors and hepatic stellate cell activation. J. Biol. Chem., 275, 35715-35722 (2000).
21. Morgan, D. O., Principles of CDK regulation. Nature, 374, 131-134 (1996).
22. Ohata, M., Suzuki, H., Sakamoto, K., Hashimoto, K., Nakajima, H., Yamauchi, M., Hokkyo, K., Yamada, H., and Toda, G., Pioglitazone prevents acute liver injury induced by ethanol and lipopolysaccharide through the suppression of tumor necrosis factor-a. Alcohol. Clin. Exp. Res., 28, 139S-144S (2004).
23. Pines, M., Knopov, V., Genina, O., Lavelin, I., and Nagler, A., Halofuginone, a specific inhibitor of collagen type I synthesis, prevents dimethylnitrosamine-induced liver cirrhosis. J. Hepatol., 27, 391-398 (1997).
24. Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., Liang, T. J., Yanovski, J. A., Kleiner, D. E., and Hoofnagle, J. H., A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology, 39, 188-196 (2004).
25. Rangwala, S. M. and Lazar, M. A., Peroxisome proliferatoractivated receptor gamma in diabetes and metabolism. Trends Pharmacol. Sci., 25, 331-336 (2004).
26. Reeves, H. L. and Friedman, S. L., Activation of hepatic stellate cells-a key issue in liver fibrosis. Front Biosci., 7, 808-826 (2002).
27. Sakaida, I., Matsumura, Y., Kubota, M., Kayano, K., Takenaka, K., and Okita, K., The prolyl 4-hydroxylase inhibitor HOE- 077 prevents activation of Ito Cells, reducing procollagen gene expression in rat liver fibrosis induced by cholinedeficient L-amino acid-defined diet. Hepatology, 23, 755-763 (1996).
28. Sato, O., Kuriki, C., Fukui, Y., and Motojima, K., Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J. Biol. Chem., 277, 15703-15711 (2002).
29. Sherr, C. J. and Roberts, J. M., CDK inhibitors: positive and negative regulators of G1 phase progression. Genes Dev., 13, 1501-1512 (1999).
30. Tada, S., Nakamuta, M., Enjoji, M., Sugimoto, R., Iwamoto, H., Kato, M., Nakashima, Y., and Nawata, H., Pirfenidone inhibits dimethylnitrosamine-induced hepatic fibrosis in rats. Clin Exp. Pharmacol. Physiol., 28, 522-527 (2001).
31. Vogel, S., Piantedosi, R., Frank, J., Lalazar, A., Rockey, D. C., Friedman, S. L., and Blaner, W. S., An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res., 41, 882-893 (2000).
32. Wang, C., Fu, M., D'Amico, M., Albanese, C., Zhou, J. N., Brownlee, M., Lisanti, M. P., Chatterjee, V. K., Lazar, M. A., and Pestell, R. G., Inhibition of cellular proliferation through IkappaB kinase-independent and peroxisome proliferator-activated receptor gamma-dependent repression of cyclin D1. Mol. Cell. Biol., 21, 3057-3070 (2001).
33. Wu, J. and Norton, P. A., Animal models of liver fibrosis. Scand. J. Gastroenterol., 31, 1137-1143 (1996).
34. Xu, J., Fu, Y., and Chen, A., Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am. J. Physiol. Gastrointest. Liver Physiol., 285, 20-30 (2003).
35. Zhao, W. X., Zhao, J., Liang, C. L., Zhao, B., Pang, R. Q., and Pan, X. H., Effect of caffeic acid phenethyl ester on proliferation and apoptosis of hepatic stellate cells in itro. World J. Gastroenterol., 9, 1278-1281 (2003).